Forte Biosciences, Inc. (FBRX)
NASDAQ: FBRX · Real-Time Price · USD
21.55
-0.45 (-2.07%)
At close: May 22, 2026, 4:00 PM EDT
21.59
+0.04 (0.21%)
After-hours: May 22, 2026, 4:10 PM EDT
Forte Biosciences Market Cap
Forte Biosciences has a market cap or net worth of $527.57 million as of May 22, 2026. Its market cap has increased by 1,186.29% in one year.
Market Cap
527.57M
Enterprise Value
469.34M
1-Year Change
1,186.29%
Ranking
Category
Stock Price
$21.55
Market Cap Chart
Since June 16, 2020, Forte Biosciences's market cap has increased from $181.43M to $527.57M, an increase of 190.78%. That is a compound annual growth rate of 19.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 527.57M | 8.49% |
| Dec 31, 2025 | 486.26M | 234.91% |
| Dec 31, 2024 | 145.19M | 386.30% |
| Dec 29, 2023 | 29.86M | 42.17% |
| Dec 30, 2022 | 21.00M | -33.49% |
| Dec 31, 2021 | 31.57M | -93.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| XOMA Royalty | 526.47M |
| Kyverna Therapeutics | 518.74M |
| Sutro Biopharma | 515.76M |
| Prime Medicine | 511.15M |
| ProKidney | 510.31M |
| Ginkgo Bioworks Holdings | 504.31M |
| Climb Bio | 502.53M |
| Contineum Therapeutics | 500.60M |